Home Boxes

Camlipixant (BLU-5937)

Developing a Promising Therapeutic Candidate

Advancing a potential solution for refractory chronic cough.

Learn More

Clinical Trials

Investigating the Promise of Camlipixant

Ongoing Phase 3 trials, CALM-1 and CALM-2, in refractory chronic cough.

Learn More

Patients

Patients are at the Heart of What We Do

Committed to patients struggling with refractory chronic cough.

Watch Video

Careers

Help us
Transform
Lives

Join our experienced team of diverse and resilient professionals dedicated to developing breakthrough treatments.

Learn More